NCT04838561View on ClinicalTrials.gov

Assessing the Impact of Control-IQ Technology

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

October 26, 2021

Study Completion Date

October 26, 2021

Conditions
Type 1 Diabetes
Trial Locations (1)

K1H8L1

Children's Hospital of Eastern Ontario, Ottawa

All Listed Sponsors
collaborator

Tandem Diabetes Care, Inc.

INDUSTRY

lead

Children's Hospital of Eastern Ontario

OTHER

NCT04838561 - Assessing the Impact of Control-IQ Technology | Biotech Hunter | Biotech Hunter